[1]
Foroutan, N. et al. 2018. BUDGET IMPACT ANALYSIS OF USING OMEPRAZOLE IMMEDIATE-RELEASE ORAL SUSPENSION IN REPLACE OF INTRAVENOUS PANTOPRAZOLE IN CRITICALLY ILL PATIENTS. Journal of Population Therapeutics and Clinical Pharmacology. 22, 3 (Nov. 2018).